Neuromodulators and Therapeutic Targets in Neuropathic Pain: From Molecules to Man

Author(s): P. E. Bermejo, B. Anciones

Journal Name: CNS & Neurological Disorders - Drug Targets
Formerly Current Drug Targets - CNS & Neurological Disorders

Volume 8 , Issue 3 , 2009

Become EABM
Become Reviewer
Call for Editor


Neuropathic pain is a phenomenon characterized by a high population prevalence by possessing several etiologies. In contrast to nociceptive pain, painful signals in neuropathic pain are originated in the nervous system, present poor responses to conventional treatments and may worsen the quality of life. Antiepileptic drugs are increasingly used for different purposes including migraine, neuropathic pain, tremor or psychiatric disorders and they have started to be called neuromodulators. These drugs may act on very different targets such as sodium, potassium or calcium channels, purinergic, GABAergic, glutamatergic or vanilloid receptors and different cytokines including IL-6 or TNF, each if which may be important in managing some aspects of neuropathic pain. Antiepileptic drugs have demonstrated effectiveness in the treatment of this pathology, and owing to the important development of these drugs in the last years, they may become a very effective tool. On the other hand, the increasing knowledge of the pathophysiology of nociception is leading to new channels and receptors as potential targets for treatment. In this paper we try to review the different potential therapeutic targets and role of antiepileptic drugs in the treatment of this pathology.

Keywords: Antiepileptic, neuromodulator, neuropathic pain, gabapentin pregabalin, topiramate, zonisamide, oxcarbacepine

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2009
Page: [175 - 183]
Pages: 9
DOI: 10.2174/187152709788680661
Price: $65

Article Metrics

PDF: 12